Profile
Charles L.
Dimmler is the founder of Ceramedix, Inc., established in 2020, where the title held is Executive Chairman.
The current job is Managing Principal at Newcastle Harbor LLC, starting in 2003.
Former jobs include President & Chief Executive Officer at Gene Logic, Inc. from 1996 to 2008, President & Chief Executive Officer at Ore Pharmaceuticals, Inc. from 2008 to 2009, and Chairman at PROMETHERA Biosciences SA from 2018 to 2020.
Education includes undergraduate studies at the University of California, Davis.
Charles L. Dimmler active positions
| Companies | Position | Start |
|---|---|---|
Newcastle Harbor LLC | Corporate Officer/Principal | 2003-11-30 |
Former positions of Charles L. Dimmler
| Companies | Position | End |
|---|---|---|
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Chairman | 2020-08-31 |
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | President | 2009-02-28 |
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Develops and discovers pharmaceutical | President | 2008-01-02 |
Training of Charles L. Dimmler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Develops and discovers pharmaceutical | Health Technology |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newcastle Harbor LLC | |
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
- Stock Market
- Insiders
- Charles L. Dimmler
















